(Q51545073)

6 April 2018

title

Subcutaneous fentanyl infusion in a patient with bowel obstruction and renal failure. (English)

1 reference

6 April 2018

0 references

1 reference

0 references

Mercadante S

1

1 reference

6 April 2018

Caligara M

2

1 reference

6 April 2018

Sapio M

3

1 reference

6 April 2018

Serretta R

4

1 reference

6 April 2018

Lodi F

5

1 reference

6 April 2018

publication date

1 April 1997

1 reference

6 April 2018

Journal of Pain and Symptom Management

published in

1 reference

6 April 2018

volume

13

1 reference

6 April 2018

issue

4

1 reference

6 April 2018

page(s)

241-244

1 reference

6 April 2018

Opioid analgesia in uraemic patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900076-6

7 January 2021

Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900076-6

7 January 2021

Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900076-6

7 January 2021

Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides after oral morphine. The influence of renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900076-6

7 January 2021

Chronic nausea and morphine-6-glucuronide

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900076-6

7 January 2021

Morphine intoxication in renal failure: the role of morphine-6-glucuronide

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900076-6

7 January 2021

Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900076-6

7 January 2021

Transdermal fentanyl for pain control in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900076-6

7 January 2021

Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900076-6

7 January 2021

An open label study of oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900076-6

7 January 2021

Use of the subcutaneous route for the administration of narcotics in patients with cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900076-6

7 January 2021

Determination of fentanyl and alfentanil in plasma by high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900076-6

7 January 2021

10.1016/S0885-3924(97)00076-6

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018